References
- Shuster A, Patlas M, Pinthus JH, Mourtzakis M. The clinical importance of visceral adiposity: a critical review of methods for visceral adipose tissue analysis. Br J Radiol. 2012;85(1009):1–10. doi:https://doi.org/10.1259/bjr/38447238
- Britton KA, Massaro JM, Murabito JM, Kreger BE, Hoffmann U, Fox CS. Body fat distribution, incident cardiovascular disease, cancer, and all-cause mortality. J Am Coll Cardiol. 2013;62(10):921–25. doi:https://doi.org/10.1016/j.jacc.2013.06.027
- Kahn HS. The “lipid accumulation product” performs better than the body mass index for recognizing cardiovascular risk: a population-based comparison. BMC Cardiovasc Disord. 2005;5(1):26. doi:https://doi.org/10.1186/1471-2261-5-26
- Schaffer JE. Lipotoxicity: when tissues overeat. Curr Opin Lipidol. 2003;14(3):281–87. doi:https://doi.org/10.1097/00041433-200306000-00008
- Ioachimescu AG, Brennan DM, Hoar BM, Hoogwerf BJ. The lipid accumulation product and all-cause mortality in patients at high cardiovascular risk: a PreCIS database study. Obesity (Silver Spring). 2010;18(9):1836–44. doi:https://doi.org/10.1038/oby.2009.453
- Wakabayashi I. Influence of age and gender on lipid accumulation product and its relation to diabetes mellitus in Japanese. Clin Chim Acta. 2014;431:221–26. doi:https://doi.org/10.1016/j.cca.2014.02.002
- Franklin SS, Khan SA, Wong ND, Larson MG, Levy D. Is pulse pressure useful in predicting risk for coronary heart disease? The framingham heart study. Circulation. 1999;100(4):354–60. doi:https://doi.org/10.1161/01.cir.100.4.354
- Winston GJ, Palmas W, Lima J, Polak JF, Bertoni AG, Burke G, Eng J, Gottesman R, Shea S. Pulse pressure and subclinical cardiovascular disease in the multi-ethnic study of atherosclerosis. Am J Hypertens. 2013;26(5):636–42. doi:https://doi.org/10.1093/ajh/hps092
- Franklin SS, Larson MG, Khan SA, Wong ND, Leip EP, Kannel WB, Levy D. Does the relation of blood pressure to coronary heart disease risk change with aging? The framingham heart study. Circulation. 2001;103(9):1245–49. doi:https://doi.org/10.1161/01.cir.103.9.1245
- Larstorp AC, Ariansen I, Gjesdal K, Olsen MH, Ibsen H, Devereux RB, Okin PM, Dahlöf B, Kjeldsen SE, Wachtell K. Association of pulse pressure with new-onset atrial fibrillation in patients with hypertension and left ventricular hypertrophy: the Losartan Intervention For Endpoint (LIFE) reduction in hypertension study. Hypertension. 2012;60(2):347–53. doi:https://doi.org/10.1161/HYPERTENSIONAHA.112.195032
- Kitagawa N, Ushigome E, Matsumoto S, Oyabu C, Ushigome H, Yokota I, Asano M, Tanaka M, Yamazaki M, Fukui M. Threshold value of home pulse pressure predicting arterial stiffness in patients with type 2 diabetes: KAMOGAWA-HBP study. J Clin Hypertens (Greenwich). 2018;20(3):472–77. doi:https://doi.org/10.1111/jch.13209
- Pääkkö TJW, Perkiömäki JS, Kesäniemi YA, Ylitalo AS, Lumme JA, Huikuri HV, Ukkola OH. Increasing ambulatory pulse pressure predicts the development of left ventricular hypertrophy during long-term follow-up. J Hum Hypertens. 2018;32(3):180–89. doi:https://doi.org/10.1038/s41371-018-0034-5
- Gottesman R, Shea S. Pulse pressure and subclinical cardiovascular disease in the multi-ethnic study of atherosclerosis. Am J Hypertens. 2013;26(5):636–42. doi:https://doi.org/10.1093/ajh/hps092
- Karastergiou K, Smith SR, Greenberg AS, Fried SK. Sex differences in human adipose tissues - the biology of pear shape. Biol Sex Differ. 2012;3(1):13. doi:https://doi.org/10.1186/2042-6410-3-13
- Yoon H. Association between pulse pressure and impaired pulmonary function in non-smoking adults. Korean J Clin Lab Sci. 2020;52(2):119–27. doi:https://doi.org/10.15324/kjcls.2020.52.2.119
- Rivera-Mancía S, Colín-Ramírez E, Cartas-Rosado R, Infante O, Vargas-Barrón J, Vallejo M. Indicators of accumulated fat are stronger associated with prehypertension compared with indicators of circulating fat: a cross-sectional study. Medicine (Baltimore). 2018;97(34):e11869. doi:https://doi.org/10.1097/MD.0000000000011869
- Kaneva AM, Bojko ER. Age-adjusted cut-off values of lipid accumulation product (LAP) for predicting hypertension. Sci Rep. 2021;11(1):11095. doi:https://doi.org/10.1038/s41598-021-90648-y
- Han SJ, Fujimoto WY, Kahn SE, Leonetti DL, Boyko EJ. Change in visceral adiposity is an independent predictor of future arterial pulse pressure. J Hypertens. 2018;36(2):299–305. doi:https://doi.org/10.1097/HJH.0000000000001532
- Kotani K, Adachi S, Tsuzaki K, Sakane N. Relationship between the abdominal wall fat index and blood pressure in elderly women: a comparison with the body mass index. Aging Clin Exp Res. 2009;21(4–5):349–52. doi:https://doi.org/10.1007/BF03324926
- Capoulade R, Larose E, Mathieu P, Clavel MA, Dahou A, Arsenault M, Bédard E, Larue-Grondin S, Le Ven F, Dumesnil JG, et al. Visceral adiposity and left ventricular mass and function in patients with aortic stenosis: the PROGRESSA study. Can J Cardiol. 2014;30(9):1080–87. doi:https://doi.org/10.1016/j.cjca.2014.02.007
- Bays HE, González-Campoy JM, Bray GA, Kitabchi AE, Bergman DA, Schorr AB, Rodbard HW, Henry RR. Pathogenic potential of adipose tissue and metabolic consequences of adipocyte hypertrophy and increased visceral adiposity. Expert Rev Cardiovasc Ther. 2008;6(3):343–68. doi:https://doi.org/10.1586/14779072.6.3.343
- Ryo M, Nakamura T, Kihara S, Kumada M, Shibazaki S, Takahashi M, Nagai M, Matsuzawa Y, Funahashi T. Adiponectin as a biomarker of the metabolic syndrome. Circ.J. 2004;68(11):975–81. doi:https://doi.org/10.1253/circj.68.975
- Qiao L, Zou C, van der Westhuyzen DR, Shao J. Adiponectin reduces plasma triglyceride by increasing VLDL triglyceride catabolism. Diabetes. 2008;57(7):1824–33. doi:https://doi.org/10.2337/db07-0435
- Lee S, Kwak HB. Role of adiponectin in metabolic and cardiovascular disease. J Exerc Rehabil. 2014;10(2):54–59. doi:https://doi.org/10.12965/jer.140100
- Shibata R, Ouchi N, Ito M, Kihara S, Shiojima I, Pimentel DR, Kumada M, Sato K, Schiekofer S, Ohashi K, et al. Adiponectin-mediated modulation of hypertrophic signals in the heart. Nat Med. 2004;10(12):1384–89. doi:https://doi.org/10.1038/nm1137
- Wang H, Sun Y, Li Z, Guo X, Chen S, Ye N, Tian Y, Zhang L. Gender-specific contribution of cardiometabolic index and lipid accumulation product to left ventricular geometry change in general population of rural China. BMC Cardiovasc Disord. 2018;18(1):62. doi:https://doi.org/10.1186/s12872-018-0798-0
- Li R, Li Q, Cui M, Ying Z, Li L, Zhong T, Huo Y, Xie P. Visceral adiposity index, lipid accumulation product and intracranial atherosclerotic stenosis in middle-aged and elderly Chinese. Sci Rep. 2017;7(1):7951. doi:https://doi.org/10.1038/s41598-017-07811-7
- Ray L, Ravichandran K, Nanda SK. Comparison of lipid accumulation product index with body mass index and waist circumference as a predictor of metabolic syndrome in Indian population. Metab Syndr Relat Disord. 2018;16(5):240–45. doi:https://doi.org/10.1089/met.2017.0119
- Song J, Chen X, Jiang Y, Mi J, Zhang Y, Zhao Y, Wu X, Gao H. Association and interaction analysis of lipid accumulation product with impaired fasting glucose risk: a cross-sectional survey. J Diabetes Res. 2019;2019:9014698. doi:https://doi.org/10.1155/2019/9014698
- Nguyen Ngoc H, Kriengsinyos W, Rojroongwasinkul N, Aekplakorn W. Association of adiposity indices with hypertension in middle-aged and elderly thai population: National Health Examination Survey 2009 (NHES-IV). J Cardiovasc Dev Dis. 2019;6(1):13. doi:https://doi.org/10.3390/jcdd6010013
- Pinto E. Blood pressure and ageing. Postgrad Med J. 2007;83(976):109–14. doi:https://doi.org/10.1136/pgmj.2006.048371
- Lemieux S, Prud’homme D, Bouchard C, Tremblay A, Després JP. Sex differences in the relation of visceral adipose tissue accumulation to total body fatness. Am J Clin Nutr. 1993;58(4):463–67. doi:https://doi.org/10.1093/ajcn/58.4.463
- Snijder MB, Visser M, Dekker JM, Goodpaster BH, Harris TB, Kritchevsky SB, De Rekeneire N, Kanaya AM, Newman AB, Tylavsky FA, et al. Health ABC study. Low subcutaneous thigh fat is a risk factor for unfavourable glucose and lipid levels, independently of high abdominal fat. The health ABC study. Diabetologia. 2005;48(2):301–08. doi:https://doi.org/10.1007/s00125-004-1637-7
- Fox CS, Massaro JM, Hoffmann U, Pou KM, Maurovich-Horvat P, Liu CY, Vasan RS, Murabito JM, Meigs JB, Cupples LA, et al. Abdominal visceral and subcutaneous adipose tissue compartments: association with metabolic risk factors in the framingham heart study. Circulation. 2007;116(1):39–48. doi:https://doi.org/10.1161/CIRCULATIONAHA.106.675355
- McLaughlin T, Lamendola C, Liu A, Abbasi F. Preferential fat deposition in subcutaneous versus visceral depots is associated with insulin sensitivity. J Clin Endocrinol Metab. 2011;96(11):E1756–1760. doi:https://doi.org/10.1210/jc.2011-0615
- Chen P, Hou X, Hu G, Wei L, Jiao L, Wang H, Chen S, Wu J, Bao Y, Jia W. Abdominal subcutaneous adipose tissue: a favorable adipose depot for diabetes? Cardiovasc Diabetol. 2018;17(1):93. doi:https://doi.org/10.1186/s12933-018-0734-8
- Chella Krishnan K, Mehrabian M, Lusis AJ. Sex differences in metabolism and cardiometabolic disorders. Curr Opin Lipidol. 2018;29(5):404–10. doi:https://doi.org/10.1097/MOL.0000000000000536
- Lee MJ, Fried SK. Sex-dependent depot differences in adipose tissue development and function; role of sex steroids. J Obes Metab Syndr. 2017;26(3):172–80. doi:https://doi.org/10.7570/jomes.2017.26.3.172
- Mozos I, Maidana JP, Stoian D, Stehlik M. Gender differences of arterial stiffness and arterial age in smokers. Int J Environ Res Public Health. 2017;14(6):E565. doi:https://doi.org/10.3390/ijerph14060565
- Reckelhoff JF. Gender differences in hypertension. Curr Opin Nephrol Hypertens. 2018;27(3):176–81. doi:https://doi.org/10.1097/MNH.0000000000000404
- Morrow EH. The evolution of sex differences in disease. Biol Sex Differ. 2015;6(1):5. doi:https://doi.org/10.1186/s13293-015-0023-0
- McGregor AJ, Hasnain M, Sandberg K, Morrison MF, Berlin M, Trott J. How to study the impact of sex and gender in medical research: a review of resources. Biol Sex Differ. 2016;7(Suppl 1):46. doi:https://doi.org/10.1186/s13293-016-0099-1